SCHEMBL3065254

SCHEMBL3065254

O=C(O)c1nc(-c2ccco2)cs1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.57
HSD17B10 Q99714 6/20 0.57
MEN1 O00255 9/20 0.56
KMT2A Q03164 9/20 0.56
ALDH1A1 P00352 7/20 0.56
RAB9A P51151 4/20 0.56
NPC1 O15118 3/20 0.56
PKM P14618 3/20 0.56
ALOX15 P16050 3/20 0.56
TSHR P16473 1/20 0.56
CYP19A1 P11511 1/20 0.54
HTT P42858 1/20 0.49
POLB P06746 7/20 0.49
L3MBTL1 Q9Y468 6/20 0.49
KDM4E B2RXH2 5/20 0.49
TDP1 Q9NUW8 5/20 0.49
HPGD P15428 3/20 0.49
GAA P10253 3/20 0.49
ESR1 P03372 2/20 0.49
TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3206574 0.85 MAPT (0.60) MAPTHSD17B10MEN1KMT2AALDH1A1
SCHEMBL1677361 0.81 MEN1 (0.61) MAPTHSD17B10MEN1KMT2AALDH1A1
SCHEMBL1677400 0.79 MAPT (0.60) MAPTHSD17B10MEN1KMT2AALDH1A1
SCHEMBL1677347 0.78 L3MBTL1 (0.56) MAPTHSD17B10MEN1KMT2AALDH1A1
SCHEMBL5048867 0.78 ECE1 (0.42) MAPTHSD17B10MEN1KMT2AALDH1A1
SCHEMBL14267941 0.76 MAPT (0.53) MAPTHSD17B10MEN1KMT2AALDH1A1
SCHEMBL1677251 0.76 NPC1 (0.60) MAPTHSD17B10MEN1KMT2AALDH1A1
SCHEMBL167820 0.75 RAB9A (0.58) MAPTHSD17B10MEN1KMT2AALDH1A1
SCHEMBL11038522 0.74 MEN1 (0.71) MAPTHSD17B10MEN1KMT2AALDH1A1
SCHEMBL7253210 0.73 CYP19A1 (0.72) MAPTHSD17B10MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100280023-A1 THIAZOLE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 2010-11-04 US disclosed
EP-1894930-A1 THIAZOLE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280023-A1 THIAZOLE DERIVATIVES ADORA2A, ADORA3, GPR6 MAPT 3668/4885HSD17B10 1946/4885MEN1 4255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.